Francisco J. Caballero-Camino

Genetics, pathobiology and therapeutic opportunities of polycystic liver disease

N. LaRusso, P. Rodrigues, J. Banales, 2022, Nature Reviews Gastroenterology & Hepatology.

Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models.

D. Calvisi, M. Avila, L. Fabris, 2022, Journal of hepatology.

Inhibition of NAE‐dependent protein hyper‐NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease

J. Drenth, M. Martínez-Chantar, P. Rodrigues, 2021, United European gastroenterology journal.

Genetics, pathobiology and therapeutic opportunities of polycystic liver disease

N. LaRusso, P. Rodrigues, J. Banales, 2022, Nature Reviews Gastroenterology & Hepatology.

Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets

N. LaRusso, J. Drenth, P. Rodrigues, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease

M. Esteller, J. Marin, P. Rodrigues, 2020, Hepatology.

Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models

N. LaRusso, J. Drenth, P. Rodrigues, 2020, Journal of hepatology.

Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma

T. Karlsen, M. Krawczyk, M. Vesterhus, 2023, Journal of hepatology.